An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Findings support model in which accelerated biological aging of mammary epithelia may underpin breast cancer susceptibility ...
PanGIA Biotech, Inc. ("PanGIA Biotech" or "Company") announced that two research abstracts have been accepted for ...
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
Researchers at City of Hope, a cancer research and treatment organization, and the University of California, Berkeley, have ...
The United States Food and Drug Administration (FDA) issued guidance on its “Breakthrough Devices Program” in 2023. The ...
TOBY, Inc., a biotechnology company developing non-invasive cancer screening technologies, today announced that the U.S. Food ...
Brazilian researchers have developed an electrochemical sensor that can detect pancreatic cancer in its early stages. The ...
Researchers have introduced groundbreaking tools—from a microfluidic platform measuring breast cell 'mechanical age' to AI-driven mammogram risk assessments—that could transform breast cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results